Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | METAP2 | P50579 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 2/20 | 0.31 |
| ▸ | TNKS | O95271 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13326605 | 0.86 | ALOX5 (0.43) | ALOX5GPR84EGFRERBB2ALDH1A1 | |
| SCHEMBL18083574 | 0.86 | GPR84 (0.36) | ALOX5GPR84CYP1A2CYP2A6P2RX4 | |
| SCHEMBL16502134 | 0.83 | ALDH1A1 (0.40) | GPR84EGFRERBB2ALDH1A1KDM4E | |
| SCHEMBL16502133 | 0.82 | ALDH1A1 (0.46) | ALOX5EGFRERBB2ALDH1A1CYP1A2 | |
| SCHEMBL16502146 | 0.80 | FAAH (0.39) | ALDH1A1KDM4EHPGDCYP2C9SMN1; SMN2 | |
| SCHEMBL16502148 | 0.79 | ALDH1A1 (0.43) | EGFRERBB2ALDH1A1CYP1A2CYP2A6 | |
| SCHEMBL16502126 | 0.78 | ALDH1A1 (0.38) | ALDH1A1CYP1A2KDM4EHPGDCYP3A4 | |
| SCHEMBL13326575 | 0.78 | ABCG2 (0.40) | ALOX5GPR84EGFRERBB2ALDH1A1 | |
| SCHEMBL12620253 | 0.76 | ALOX5 (0.38) | ALOX5GPR84KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL13147457 | 0.76 | NPSR1 (0.33) | ALOX5GPR84ALDH1A1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210359214-A1 | ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-11-18 | — | — | US | disclosed |
| US-7718278-B2 | Anthrancene derivative compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2010-05-18 | — | — | US | disclosed |
| US-7718278-B2 | Anthrancene derivative compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2010-05-18 | — | — | US | disclosed |
| US-20080122346-A1 | ANTHRANCENE DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-05-29 | — | — | US | disclosed |
| US-20080122346-A1 | ANTHRANCENE DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080122346-A1 | ANTHRANCENE DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | AR, CRY2, ANTXR2 | ALOX5 2198/4885GPR84 2192/4885EGFR 3783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.